Protein of Leishmania which is expressed at an increased level i

Details Protein of Leishmania which is expressed at an increased level i Protein of Leishmania which is expressed at an increased level i

1995-06-02

1998-07-14

Caputa, Anthony C.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

530395, 530820, 530822, 4242651, 4242661, C07K 1444, A61K 39008

Patent

active

057805911

ABSTRACT:
Differentially expressed Leishmania genes and proteins are described. One differentially expressed gene (A2) is expressed at significantly elevated levels (more than about 10 fold higher) in the amastigote stage of the life cycle when the Leishmania organism is present in macrophages than in the free promastigote stage. The A2 gene encodes a 22 kD protein (A2 protein) that is recognized by kala-azar convalescent serum and has amino acid sequence homology with an S-antigen of Plasmodium falciparum Vietnamese isolate VI. Differentially expressed Leishmania genes and proteins have utility as vaccines, diagnostic reagents, as tools for the generation of immunological reagents and the generation of attenuated variants of Leishmania.

REFERENCES:
patent: 4687666 (1987-08-01), O'Daly
patent: 4744983 (1988-05-01), Morein
patent: 4764370 (1988-08-01), Fields et al.
patent: 4801530 (1989-01-01), Nogueira et al.
patent: 4879213 (1989-11-01), Fox et al.
patent: 4908308 (1990-03-01), Van der Ploeg et al.
patent: 4992273 (1991-02-01), Monjour et al.
patent: 5047522 (1991-09-01), Nogueira et al.
Brown et al. Mol. Biol. Med. 4(6):365-76 (see abstract), 1987.
Charest et al. Mol. Cell Biology 14(5):2975-84 (see abstract), May, 1994.
Jaffe et al. Infection and Immunity 57(12)3770-3777, 1988.
Kumar et al. PNAS 87:1337-1341, 1990.
Bowie et al. Science 247:1306-1310, 1990.
Vaccines S.A. Plotkin et al. (Ed.), published by W.B. Saunders Company (Philadelphia), see Chapter 29, pp. 568-575, 1988.
Vaccines And Immunotherapy, S. J. Cryz (Ed.), published by Pergamon Press (New York), see Chapter 17, pp. 211-223, 1991.
Sheppard et al. Molecular and Biochemical Parasitology 19:35-43, 1986.
WHO, Tropical Disease Report, 1989. pp. 85-92.
Turco, S.J., and Descoteaux, A. 1992. The Lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46:65-94.
Sacks, D.L. 1989. Metacyclogenesis in Leishmania promastigotes. Exp. Parasitology. 69:100-103.
Sacks D.L., and da Silva, R.P. 1987. The generation of infective stage L. major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid. J. Immunol. 139:3099-3106.
Sacks, D.L., Brodin T.N., Turco, S.J. 1990. Developmental modification of the lipophosphoglycan from L. major promastigotes during metacyclogenesis. Mol. Biochemical Parasitol. 42:225-234.
Medina-Acosta, E., Karess, R.E., Schwartz H., and Russell, D.G. 1989. The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage. Mol. Biochemical Parasitol. 37:263-274.
Turco, S.J. and Sacks, D.L. 1991. Expression of stage-specific lipophosphoglycan in Leishmania major amastigotes. Mol. Biochemical Parasitol. 45:91-100.
McConville, M.J., and Blackwell J.M. 1991. Developmental changes in the glycosylated phosphatidylinositols of L. donovani J. Biol. Chem. 260:15170-15179.
Bogdan, C., Rollinghoff M., and Solbach, W. 1990. Evasion strategies of Leishmania parasites. Parasitol. Today. 6:183-187.
Modabber, F. 1989. Experiences with vaccines against cutaneous leishmaniasis: of men and mice. Parasitol. 98:S49-S60.
Joshi, M. Dwyer, D.M., and Nakhasi, H.L. 1993. Cloning and characterization of differentially expressed genes from in vitro-grown "amastigotes" of Leishmania donovani. Mol. Biochemical Parasitol. 58:345-354.
Descoteaux, A., and Matlashewski, G. 1989. c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages. Mol. Cell. Biol. 9:5223-5227..
Doyle, P.S. Engel, J.C., Pimenta, P.F.P. da Silva, P. and Dwyer. 1991. Leishmania donovani: Long-term culture of axenic amastigotes at 37.degree.C. Exp. Parasitol. 73:326-334.
Sambrook, J., Fritsch, E.F., and Maniatis. 1989. Molecular cloning. A laboratory guide. Cold Spring Harbor Laboratories Press, New York. pp. 7.26-7.29.
Sambrook, J., Fritsch, E.F., and Maniatis. 1989. Molecular cloning. A laboratory guide. Cold Spring Harbor Laboratories Press, New York. pp. 10.44-10.45.
Sambrook, J., Fritsch, E.F., and Maniatis. 1989. Molecular cloning. A laboratory guide. Cold Spring Harbor Laboratories Press, New York. pp. 9.38-9.40.
Sambrook, J., Fritsch, E.F., and Maniatis. 1989. Molecular cloning. A laboratory guide. Cold Spring Harbor Laboratories Press, New York. pp. 4.48.
Cruz,A., and Beverley, S.M. 1990. Gene-replacement in parasitic protozoa. Nature 348:171-173.

Affiliated with

Also associated with

Rating

Protein of Leishmania which is expressed at an increased level i does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein of Leishmania which is expressed at an increased level i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein of Leishmania which is expressed at an increased level i will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1882782